- Home
- SVCC vs NYXH Comparison
SVCC vs NYXH Comparison
Compare SVCC & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVCC
- NYXH
- Stock Information
- Founded
- SVCC 2024
- NYXH 2009
- Country
- SVCC United States
- NYXH Belgium
- Employees
- SVCC N/A
- NYXH N/A
- Industry
- SVCC
- NYXH Medical/Dental Instruments
- Sector
- SVCC
- NYXH Health Care
- Exchange
- SVCC Nasdaq
- NYXH Nasdaq
- Market Cap
- SVCC 218.3M
- NYXH 222.3M
- IPO Year
- SVCC 2025
- NYXH 2021
- Fundamental
- Price
- SVCC $10.21
- NYXH $7.75
- Analyst Decision
- SVCC
- NYXH Strong Buy
- Analyst Count
- SVCC 0
- NYXH 4
- Target Price
- SVCC N/A
- NYXH $14.50
- AVG Volume (30 Days)
- SVCC 25.1K
- NYXH 76.9K
- Earning Date
- SVCC 01-01-0001
- NYXH 08-05-2025
- Dividend Yield
- SVCC N/A
- NYXH N/A
- EPS Growth
- SVCC N/A
- NYXH N/A
- EPS
- SVCC N/A
- NYXH N/A
- Revenue
- SVCC N/A
- NYXH $4,716,818.00
- Revenue This Year
- SVCC N/A
- NYXH $323.07
- Revenue Next Year
- SVCC N/A
- NYXH $204.30
- P/E Ratio
- SVCC N/A
- NYXH N/A
- Revenue Growth
- SVCC N/A
- NYXH N/A
- 52 Week Low
- SVCC $9.95
- NYXH $5.55
- 52 Week High
- SVCC $10.31
- NYXH $11.87
- Technical
- Relative Strength Index (RSI)
- SVCC N/A
- NYXH 62.70
- Support Level
- SVCC N/A
- NYXH $7.45
- Resistance Level
- SVCC N/A
- NYXH $7.85
- Average True Range (ATR)
- SVCC 0.00
- NYXH 0.27
- MACD
- SVCC 0.00
- NYXH -0.02
- Stochastic Oscillator
- SVCC 0.00
- NYXH 97.33
About SVCC Stellar V Capital Corp. Class A Ordinary Shares
Stellar V Capital Corp is a blank check company.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.